LUMIFY® (brimonidine tartrate ophthalmic solution 0.025%) is the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of ocular redness due to minor eye irritations. Its importance for eye care practice today should not be overlooked. In the following discussion, we explain reasons why optometric professionals who want to stay at the forefront of eye care developments need to take a closer look at implementing this essential product in their practices.

Supported by Bausch + Lomb.